Itovebi Coupon - Itovebi 3mg tablet

Itovebi

Used for Breast Cancer
INAVOLISIB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. Get Itovebi for as low as $22,781.52, which is 9% off the average retail price of $24,942.04 for the most common version, by using a GoodRx coupon.
INAVOLISIB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. Get Itovebi for as low as $22,781.52, which is 9% off the average retail price of $24,942.04 for the most common version, by using a GoodRx coupon.
Choose pharmacy
5%

Price with GoodRx coupon

Email or text this coupon to yourself
$23,056
Retail price:$24,942
Show this coupon at the pharmacy.
BIN015995
PCNGDC
GroupDR33
Member IDKJE299918
Sales tax may apply and is not included.
Get a savings card by mail

Local pharmacy prices

Choose a pharmacy to get a coupon
Local Pharmacy
Select this if your pharmacy isn’t listed above
* No store membership required at Sams Club or Costco

Ways to save on Itovebi

These programs and tips can help make your prescription more affordable
Gold coin

Common questions about Itovebi pricing

person using laptop
How much is Itovebi without insurance?

GoodRx offers free coupons for Itovebi which can lower the price to as little as $22,782 per month, a savings of 8.66% off the retail price. These discounts can be used without insurance.

Does Itovebi have a Manufacturer Coupon?

No. There currently is no Manufacturer Coupon for Itovebi.

Is there a generic for Itovebi?

Currently, there is no generic for Itovebi. However, GoodRx coupons, manufacturer copay cards, and patient assistance programs can help offset your cost.

How can I save on Itovebi?

GoodRx coupons can help lower the price Itovebi to $22,782 per fill.

Does Itovebi have a Patient Assistance Program?

No, Itovebi does not currently have an available Patient Assistance Program.

Other kinase inhibitors

Related Conditions